Moreover, ROC analysis revealed that the SLC22A17 methDNA hotspot had good biomarker performance (AUC = 0.79, p < 0.001, cut off = 27.33%), suggesting its potential application as a diagnostic biomarker for CM (Fig. 8B). Here, SLC22A17 is linked to cutaneous mastocytosis.